Stop Opioid Overdoes Naloxone
Fentanyl Drives Fatal Overdoses to Over 107,000 Annually in the U.S. - Healthcare Providers' Effort to Fight Back
24 août 2022 09h00 HE | Cordant Health Solutions
PORTLAND, Ore., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Cordant Health Solutions®, a leader in providing innovative tools for addiction treatment programs, is partnering with addiction treatment providers...
Featured Image for Experimental Biology and Medicine
Potential Risk for Methadone Treatment in Pregnancy
13 juil. 2022 10h00 HE | Experimental Biology and Medicine
WASHINGTON, July 13, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 12, June, 2022) identifies a potential risk to using Methadone...
“Opioid-free”: Innov
“Opioid-free”: Innovative ACL Surgery That Doesn’t Rely On Opioid Pain Pills
09 juin 2022 09h30 HE | WellSpan Health
York, Pa., June 09, 2022 (GLOBE NEWSWIRE) -- A WellSpan orthopedic surgeon is performing surgery on all patients under the age of 25 without prescribing opioids, just one method WellSpan caregivers...
Days Without Art 2008
Boston Artists, Activists to Lead Healing Walk to Mark Toll of Multiple Pandemics
18 nov. 2021 14h00 HE | SPOKE Arts
BOSTON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- A coalition of artists, activists, and local officials invite the Greater Boston community to join a Days Without Art Healing Walk on the evening of...
The Reverend Dr. LaKeesha Walrond Joins Board of Directors of Foundation for Opioid Response Efforts (FORE)
22 sept. 2021 11h16 HE | Foundation for Opioid Response Efforts
New York, Sept. 22, 2021 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) today announced that The Reverend Dr. LaKeesha Walrond, President of the New York Theological Seminary...
First-in-human clinical trial for a vaccine to treat opioid use disorders enrolls first patients
07 sept. 2021 08h30 HE | University of Minnesota Medical School
MINNEAPOLIS/ST. PAUL, Sept. 07, 2021 (GLOBE NEWSWIRE) -- The first patients have been enrolled in a phase 1 randomized placebo-controlled clinical trial to study a therapeutic vaccine for opioid use...
FORE and APF logos.jpg
CDC Updates List of Health Conditions that Can Increase the Risk of Severe Illness from COVID-19 to include Substance Use Disorders New York & Bethesda, May 10, 2021 (GLOBE NEWSWIRE) -- Health officials have released an update that individuals with substance use disorders (SUD) are at a heightened risk for serious...
Figure 1:
Sorrento Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) In Reduction of OsteoArthritis (OA) Knee Pain
28 sept. 2020 09h00 HE | Sorrento Therapeutics, Inc.
Phase 1b safety data at 6 month post-administration and Day 84 efficacy data available for all patients enrolled.No dose limiting toxicities at any of the doses tested (up to 30 ug) at 6 months...
PhytoSciences Consultants GmbH Announced West African Expansion with Launch of PhytoSciences Ghana Consultants Limited in an Ongoing Effort to Support Legalizing Medical Cannabis
22 sept. 2020 03h00 HE | PhytoSciences Consultants Ghana Limited
ACCRA, Ghana, Sept. 22, 2020 (GLOBE NEWSWIRE) -- PhytoSciences Consultants GmbH, an international consulting firm, announced the expansion of its services to West Africa, providing regulatory,...
UPMC Center for High
UPMC Center for High-Value Health Care Awarded $1 Million to Support Substance Use Disorder Care in Bedford and Somerset Counties
21 sept. 2020 10h42 HE | UPMC Health Plan
PITTSBURGH, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The UPMC Center for High-Value Health Care (Center), a nonprofit research organization housed within UPMC Health Plan, was awarded $1 million from the...